跳至主要内容
临床试验/ACTRN12622000345785
ACTRN12622000345785尚未招募未知

Feasibility and Efficacy of a Multidisciplinary Therapy Coaching Program For Individuals With Premanifest and Manifest Huntington's Disease

Perpetual Limited0 个研究点目标入组 84 人开始时间: 2022年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Forty-two individuals with premanifest HD (CAG > 39, DBS > 250, UHDRS-TMS < 5) and 42 individuals with early manifest HD (CAG > 39, UHDRS-TMS > 5, TFC > 7) will be recruited for this trial (effect size: f = .25, a = .05 and power (1- ß) = 80%). Participants will be required to provide written and informed consent prior to undertaking any study procedures.

排除标准

  • Exclusion criteria for participants will include concomitant cardiovascular, metabolic, immunological, neurological and musculoskeletal conditions as well as recent or ongoing substance abuse.

研究者

发起方
Perpetual Limited

相似试验